Trans Freight (513063)
Asset PlayScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹30.91 |
| Market Cap | ₹22.51 Cr |
| P/E Ratio | 9.51 |
| ROCE | 3.77% |
| ROE | 4.29% |
| Dividend Yield | 0% |
| Profit Growth | -14% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹17.85 — ₹32 |
| Sector | Industrial Products |
| Book Value | ₹52.56 |
Strengths
- Price ₹30.91 stands at just 0.59 times book value of ₹52.56, offering a possible Graham-style margin of safety.
- P/E of 9.51 is not demanding if current earnings are sustainable.
- Market cap of ₹23 Cr is small, so the stock is not being priced for excessive growth expectations.
- Trading well above its 52-week low of ₹17.85 shows some recovery in investor sentiment.
Concerns
- Latest quarter reports ₹0 Cr sales and ₹0 Cr net profit, suggesting operations may be stalled or non-operating.
- Profit growth is negative at -14% with 0% sales growth, showing no earnings momentum.
- ROE of 4.29% and ROCE of 3.77% are far below what a value investor should accept for a commodity business.
- Piotroski F-Score of 3/9 indicates weak financial health and poor operational efficiency.
- No dividend means shareholders receive no income while waiting for a turnaround.
AI Analysis
Let me look at Trans Freight through a Graham lens. The first thing that catches my eye is the balance sheet: book value of ₹52.56 per share against a price of ₹30.91, so I am buying at 59 paise to the rupee. In a true asset play, that discount can give me a margin of safety. But the income statement does not support the asset value. ROE is only 4.29% and ROCE only 3.77%; this is not a business compounding wealth. The latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr. That is a red flag. A company cannot be valued on its earnings power if the earnings engine is idle. The 14% profit decline and 0% sales growth tell me there is no momentum, and there is no dividend to compensate me while I wait. As for the moat, iron and steel products is a commodity-like, cyclical, capital-intensive business. I see no evidence of pricing power or a durable competitive advantage. The Piotroski score of 3 out of 9 reinforces my caution: the financial health is weak. The P/E of 9.51 looks cheap, but I must ask whether current earnings are sustainable or even real if the latest quarter is blank. Buffett would say it is far better to buy a wonderful business at a fair price than a fair business at a wonderful price. This is a below-book asset, but the return on that asset is subpar. I would call it an asset play, not a stalwart. I need proof that operations resume and that book value can generate better returns before I act.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer